Bd receives emergency use authorization for first at-home covid-19 test to use smartphone to interpret, deliver results

Franklin lakes, n.j., aug. 25, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, announced today the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) for the bd veritor™ at-home covid-19 test — the first at-home covid-19 rapid antigen test to use computer vision technology in a smartphone to interpret and provide a digital display of testing results.
BDX Ratings Summary
BDX Quant Ranking